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Multimorbidity (defined as having ⩾2 chronic 
conditions) (Chiang et al., 2018) requires the 
management of disease clusters, which can 
complicate patient care (Mair and May, 2014). 
Multimorbid patients need to juggle different 
medication regimens (e.g. multiple dosing 
schedules), which may reduce adherence 
(Harris et al., 2014), and increase the risk of 
premature mortality (Chiang et al., 2020). 
Multimorbidity is present in the majority (up to 
90%) of people diagnosed with type 2 diabetes 
(Huntley et al., 2012; Teljeur et al., 2013). 
Thus, there is growing interest in disease clus-
ters in type 2 diabetes, and the implications for 
patient outcomes, including glycaemic control 
(Chiang et al., 2018, 2020). The association 
between multimorbidity and glycaemia (based 
on the haemoglobin A1c (or HbA1c) diagnos-
tic test) is unclear (Chiang et al., 2018). 
Furthermore obesity, a major risk factor for 
type 2 diabetes (e.g. insulin resistance) (Agha 
and Agha, 2017), more than doubles the odds 
of multimorbidities (Agborsangaya et al., 
2013). Given the heightened interest in how 
multimorbidity relates to glycaemia (Chiang 
et al., 2018) and body weight (Madlock-Brown 
and Reynolds, 2019), there is a need to identify 
mechanisms underpinning these associations.
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Abstract
The relationship between multimorbidity and self-rated health is well established. This study examined 
self-rated health in relation to multimorbidity, glycaemia and body weight specifically in adults with type 2 
diabetes. Bootstrapped hierarchical logistic regression and structural equation modelling (SEM) were used 
to analyse survey data from 280 adults with type 2 diabetes. The odds of ‘fair/bad/very bad’ self-rated 
health increased 10-fold in patients with three (OR = 10.11 (3.36–30.40)) and four conditions (OR = 10.58 
(2.9–38.25)), irrespective of glycaemic control (p < 0.001). The relationship between multimorbidity 
and perceived health was more pronounced in male patients. SEM generated a model with good fit, χ2 
(CMIN) = 5.10, df = 3, p = 0.164, χ2 (CMIN)/df = 1.70, RMSEA = 0.05, CFI = 0.97, TLI = 0.95 and NFI = 0.94; self-
rated health mediated relations between multimorbidity and BMI. Overall, this study highlights the potential 
of self-rated health to mediate relationships between multimorbidity and BMI, but not glycaemic control, in 
adults with type 2 diabetes.
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Self-rated health
The relationship between self-rated health and 
multimorbidity is well documented (Bustos-
Vazquez et al., 2017; Galenkamp et al., 2011; 
Ishizaki et al., 2019; Kaneva et al., 2018; 
Mavaddat et al., 2014; Song et al., 2018). For 
example, a population-based study of 25,268 
middle-aged and older adults (aged 39–
79 years) recruited from general practice regis-
ters (Mavaddat et al., 2014) found the odds of 
‘moderate/poor’ self-rated health was approxi-
mately twice as high in people with two or 
more conditions, compared to those reporting 
only one condition. Research has also found a 
link between self-rated health and glycaemic 
control. For example, analysis of data from 
606 patients with type 2 diabetes (median age 
65.6 years) found that poorer perceived health 
was associated with higher HbA1c despite 
adjusting for covariates such as symptoms, 
antidiabetic medication and fatigue (Nielsen 
et al., 2011). There is also a robust (albeit con-
ditional) relationship between self-rated health 
and body weight. An analysis of data from 70 
countries (160,099 participants) found that 
body mass index (BMI) was negatively associ-
ated with poor self-rated health, in both men 
and women, from low-income countries (the 
relationship was reversed in women from mid-
dle-income countries) (Wang and Arah, 2015). 
Thus, the association between perceived health 
and bodyweight depended on gender and 
socio-economic background. Regardless, most 
of the aforementioned studies on self-rated 
health and multimorbidity used national sur-
vey data, or samples from the general popula-
tion. Few investigations have focused on 
patients with a specific chronic disease. It 
remains unclear how self-rated health relates 
to multimorbidity, and concomitant glycaemia 
and obesity, in patients with type 2 diabetes.
Glycaemia
Glycaemic control in people with diabetes is 
typically assessed using the HbA1c test (gauges 
average glucose levels in the past 2–3 months) 
(Sherwani et al., 2016). Although multimorbid-
ity correlates with glycaemic control, evidence 
is mixed. A recent systematic review found that 
10 of 14 studies reported no significant relation-
ship between multimorbidity and HbA1c; by 
contrast, 4 out of the 14 studies found that 
higher levels of multimorbidity were associated 
with elevated HbA1c (Chiang et al., 2018). The 
discrepancies may be partly attributable to vari-
ance in self-rated health, since perceived health 
is related to both multimorbidity (Mavaddat 
et al., 2014) and glycaemia (Abualula et al., 
2018; Nielsen et al., 2011). For example, it is 
possible people living with more chronic condi-
tions develop poor perceptions of health that in 
turn inhibit diabetes self-management practices 
(Idler and Benyamini, 1997), resulting in poor 
glycaemic control (Nielsen et al., 2011). Thus, 
there is a need to understand, not just how mul-
timorbidity relates to self-rated health 
(Mavaddat et al., 2014), but also how the latter 
influences multimorbidity–HbA1c relations. 
Hitherto, this issue has not been addressed in 
the literature (Chiang et al., 2018).
Obesity
Several population-based studies have demon-
strated a robust relationship between multimor-
bidity and body weight (Agrawal and Agrawal, 
2016; Booth et al., 2014; Kivimaki et al., 2017). 
For example, an analysis of cross-sectional data 
from 40,166 participants across six countries 
found that prevalence of non-communicable 
disease multimorbidity was 1.5 times higher in 
people with obesity, compared to people of nor-
mal weight (Agrawal and Agrawal, 2016). A 
study of the electronic health records of 300,006 
adults aged ⩾30 years found a positive associa-
tion between multimorbidity and obesity (Booth 
et al., 2014). Another investigation analysed 
pooled data on body weight and cardio-meta-
bolic multimorbidity from 120,813 adults, 
across 16 cohort studies (Kivimaki et al., 2017). 
The probability of multimorbidity increased 
given elevated BMI scores; the risk of multi-
morbidity was double in people who are over-
weight, and over 10 times in those with severe 
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obesity, compared to those of normal weight. 
While self-rated health has been strongly asso-
ciated with body weight (Wang and Arah, 
2015), it is unclear to what extent the former 
explains the multimorbidity–BMI relationship. 
As suggested earlier, people experiencing mul-
tiple illnesses may evaluate their health nega-
tively, thereby negating self-care practices 
essential for weight control. Alternatively, obe-
sity may elicit poor perceived health, leading to 
health-compromising behaviours that accentu-
ate both multimorbidity and obesity (Idler and 
Benyamini, 1997). Further research is needed 
to test these potential mediator effects.
Research objectives
The aims of this investigation were to (a) assess 
the association between multimorbidity and 
self-rated health in patients with type 2 diabetes 
and (b) analyse the structural relationships 
between multimorbidity, HbA1c and body 
weight, whereby self-rated health is treated as a 
mediating factor. The study addressed two spe-
cific research questions:
1. Is multimorbidity associated with self-
rated health in people diagnosed with 
type 2 diabetes? Based on previous 
research with a general population of 
patients (Mavaddat et al., 2014), it was 
hypothesised that the odds of poor per-
ceived health is significantly higher in 
patients with multimorbidity (i.e. ⩾2 
conditions), compared to patients with-
out multimorbidity (Hypothesis 1). It 
was expected that this association per-
sists even after accounting for glycae-
mia (HbA1c), body weight (BMI) and 
other clinical characteristics.
2. Is the structural relationship between 
multimorbidity and both HbA1c and 
BMI in people with type 2 diabetes 
mediated by self-rated health? Since 
perceived health has been associated 
with multimorbidity (Bustos-Vazquez 
et al., 2017), glycaemia (Nielsen et al., 
2011) and BMI (Wang and Arah, 2015), 
it was hypothesised that multimorbidity 
is indirectly related to both HbA1c and 
body weight, mediated by self-rated 
health; greater multimorbidity, HbA1c 
and BMI levels are underpinned by poor 
perceived health (Hypothesis 2). A 
direct association between multimor-
bidity and HbA1c was not expected due 
to weak support from multiple studies 
(Chiang et al., 2018).
Methodology
Ethics
Ethics approval for this study was provided by 
the university research ethics committee, based 
on a wider project involving the Health Survey 
for England (approval number 16/NSP/035). 
The study was performed in accordance with 
ethical standards as laid down in the 1964 
Declaration of Helsinki and its later amend-
ments or comparable ethical standards.
Study sample and design
Patient data was extracted from the 2017 Health 
Survey for England, a national population 
review conducted annually in the UK (Mindell 
et al., 2012). Inclusion criteria were as follows: 
(1) had been diagnosed with type 2 diabetes by a 
doctor or nurse, at the time of the survey, (2) was 
aged 16 years or older, (3) provided data on 
number of chronic conditions, and self-rated 
health. Although HbA1c ⩾ 6.5% is used to diag-
nose diabetes, this threshold was not an inclu-
sion requirement due to potentially misleading 
fluctuations in patients with type 2 diabetes (e.g. 
falsely lowered HbA1c that does not accurately 
reflect true average glycaemia, and suggesting a 
participant does not have diabetes) (Radin, 
2014). Exclusion criteria were as follows: (1) 
had been diagnosed with type 1 diabetes by a 
doctor or nurse, at the time of the survey; (2) 
aged below 16 years; (3) had no data on number 
of chronic conditions, and self-rated health. 
The study recruitment sequence is outlined in 
Figure 1. Overall, 9472 (94.8%) respondents 
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Respondents assessed for 
eligibility (i.e., people diagnosed 
with type 2 diabetes) (n= 9982)
Diagnosed with type 1 (n = 55)
Not been diagnosed by a
doctor/nurse (n = 20)
Not sure which type (n = 49)
Respondents with data on 
number of long-lasting illnesses 
(0 to 5 LTC) (n = 280)
Recruited (i.e., diagnosed with 
type 2 diabetes (n = 510)
Respondents with data on self-





Excluded (n = 9472)
Ineligible (not diagnosed with 
type 2 diabetes) (n = 9472)  
Missing data (n = 0)
Missing data (n = 230)
Missing data (n = 0)
Respondents with HbA1c (%) 
data (n = 185)
Analysed (n = 280)
Hierarchical logistic regression
Structural equation modelling, 
with maximum likelihood and 
bollen-stine bootstrapping
Missing data (n = 95 (33.9%)). 
Expectation-maximisation (EM)
used to estimate missing data
Missing data (n = 0)Data analysis
Inclusion
Figure 1. STROBE flow diagram.
were ineligible. Of the remainder, 510 (5.1%) 
had been diagnosed with type 2 diabetes, and of 
this number 280 (2.8%) patients met the eligibil-
ity criteria.
Self-rated health
Self-rated health has historically been measured 
using three to five ordinal categories depicting 
favourable, neutral and unfavourable evalua-
tions (e.g. ‘poor’, ‘fair’, ‘good’) (Idler and 
Benyamini, 1997). The national survey 
employed five options: ‘very bad’ (0), ‘bad’ (1), 
‘fair’ (2), ‘good’ (3) and ‘very good’ (4). 
Measures are typically collapsed into a dichoto-
mous variable, with just two categories (e.g. 
‘bad/fair’ vs ‘good’) (Bourne, 2009; Manor 
et al., 2000), due to the paucity of patients in the 
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‘bad’ (12.9%) and ‘very bad’ (5%) categories 
(Mavaddat et al., 2014)).
Socio-demographics and morbidity
Age was assessed using eight bands (e.g. 16–
24, 25–34, up to 65–74, ⩾75), dichotomised as 
‘younger’ (0–64 years) and ‘older’ (⩾65). 
Socio-economic class was based on eight 
groupings (e.g. higher/lower managerial, inter-
mediate, semi-routine/routine, unemployed), 
categorised as ‘lower’ (coded 0) versus ‘higher’ 
(coded 1). Multimorbidity was based on the 
number of reported chronic conditions (up to 
5). Five dummy variables were created, with 
zero (0) multimorbidity treated as the reference 
category: one condition (1 (coded 1) vs 0 (coded 
0)), two conditions (2 (coded 1) vs 0 (coded 0)), 
three conditions (3 (coded 1) vs 0 (coded 0)), 
four conditions (4 (coded 1) vs 0 (coded 0)) and 
five conditions (5 (coded 1) vs 0 (coded 0)). For 
descriptive purposes, an additional dummy var-
iable was generated; multimorbidity absent (<2 
conditions (coded 0)) versus present (⩾2 condi-
tions (coded 1)).
The data were also reviewed for comorbidi-
ties. Four relevant chronic conditions were 
identified: asthma/COPD, heart disease, obe-
sity and anxiety/depression. All are well docu-
mented chronic complications of diabetes 
(Ehrlich et al., 2010; Khan et al., 2019; Smail, 
2019). Respondents indicated if they had ever 
had a heart attack (including myocardial infarc-
tion or coronary thrombosis); ‘yes’ (coded 1), 
‘no’ (coded 0). They also stated if they had 
taken any prescribed asthma/COPD medica-
tions in the past 7 days; ‘no’ (coded 0) or ‘yes’ 
(coded 1). Presence of anxiety/depression was 
measured using the EQ 5D scale, from the 
EuroQol group (Rabin and de Charro, 2001); 
‘no’ (coded 0) or ‘yes’ (coded 1). Obesity was 
based on BMI figures, and dichotomised as: 
<30 (normal, overweight (coded 0)) versus 
⩾30 (obese (coded 1)).
Physiological measurements
Blood samples were drawn during the nurse 
visit, and tested for glycated haemoglobin 
(HbA1c), and total/HDL cholesterol. HbA1c 
data was available in both IFCC (International 
Federation of Clinical Chemistry) units of 
mmol/mol and also DCCT (Diabetes Control 
and Complications Trial) percentages. It was 
decided to analyse DCCT units (%), albeit 
IFCC calibration is more common in Europe 
(Goodall, 2005). The HbA1c % data was 
dichotomised; as non-diabetes (and prediabe-
tes) falls within the 4.0%–6.4% range, 6.5% 
was used as the threshold (<6.5% (coded 0) vs 
⩾6.5% (coded 1)). Since it is recommended 
that people with diabetes maintain HbA1c lev-
els below 7%, above which the risk of compli-
cations increases markedly, an additional 
dummy variable was created using this thresh-
old (<7.0% (coded 0) vs ⩾7.0% (coded 1)). 
Other clinical characteristics were also dichot-
omised, again with unhealthy values coded as 
1: HDL or ‘good cholesterol’ (⩾1 mmol/L 
(coded 0) vs <1 mmol/L (coded 1)); total cho-
lesterol (⩽5 mmol/L (coded 0) vs > 5 mmol/L 
(coded 1)). Although the survey asked patients 
whether or not they had been diagnosed with 
hypertension (high blood pressure), systolic 
and diastolic blood pressure readings were 
also available. Thus, these characteristics were 
coded separately due to their differential 
impact on health (e.g. systolic pressure is a 
more important predictor of mortality in older 
adults) (Taylor et al., 2011); systolic (⩽120 mm 
Hg (coded 0) vs >120 mm Hg (coded 1)); 
diastolic (⩽80 mm Hg (coded 0) vs > 80 mm 
Hg (coded 1)).
Data analysis
Logistic regression was used to test Hypothesis 
1. Power analysis was performed using 
G*Power 3.1.7 protocols (Faul et al., 2009), in 
order to determine the minimum required sam-
ple size, given an alpha level of 0.05, a power of 
0.80 (Gelman and Hill, 2006), a large effect size 
(odds ratio = 6.87) (Mavaddat et al., 2014) and a 
one-tailed test, where X parm п was based on 
the smallest multimorbidity count. These 
parameters generated a minimum sample size 
of N = 226. A hierarchical procedure was used 
for variable entry, in order to evaluate the 
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contributions of predictors above and beyond 
previously entered variables.
It was decided to test four models: Model 1 
(self-rated health = Intercept + Age + Gender), 
Model 2 (self-rated health = Intercept + Age + 
Gender + multimorbidity), Model 3 (self-rated 
health = Intercept + Age + Gender + multimor-
bidity + HbA1c/blood pressure/lipids) and 
Model 4 (self-rated health = Intercept + Age + 
Gender + multimorbidity + HbA1c/blood pres-
sure/lipids + comorbidities). Of interest was 
whether any significant associations between 
multimorbidity and self-rated health (Model 2) 
persisted after accounting for physiological risk 
factors (e.g. Hba1c) (Model 3), and specific 
comorbidities (Model 4). This hierarchy was 
based on the theoretical premise that comorbid-
ity is either embedded within the broader con-
cept of multimorbidity (and hence does not 
explain additional variance in outcome data), or 
is a completely different entity from multimor-
bidity (in which case comorbidity may predict 
additional variance, over and beyond that attrib-
utable to multimorbidity) (Lefevre et al., 2014). 
Nevertheless, this proposition remains the sub-
ject of ongoing debate about the definition of 
multimorbidity, which is beyond the scope of 
this paper (Lefevre et al., 2014).
SEM was performed to test Hypothesis 2 
(i.e. the relationship of multimorbidity with 
HbA1c and BMI is mediated by self-rated 
health). A sample size of 200 or larger is rec-
ommended for SEM models (Kline, 2011). 
The main test of model fit (χ2 goodness-of-fit) 
is affected by sample size, but performs ade-
quately given 200–300 participants (Kenny, 
2012). The present analysis was based on data 
from the whole sample (N = 280), using IBM 
AMOS SPSS statistical pack-age (Version 26). 
The modelling was conducted as path analysis, 
and rectangles represented measured varia-
bles. It was decided to use maximum likeli-
hood estimation, which meant treating both 
multimorbidity (i.e. number of conditions; 
0–5) and self-rated health (0 = ‘bad/very bad’ 
(0), ‘fair’ (1), ‘good’ (2) and ‘very good’ (3)) 
as continuous variables. Maximum likelihood 
estimation assumes multivariate normality. 
Thus, all key variables were tested for skew-
ness, and kurtosis, based on the general princi-
ple that skewness between −0.5 and 0.5 
indicates symmetrical data, and kurtosis close 
to 0 (less than 3.00) denotes a normal distribu-
tion. The skewness for HbA1c, BMI, self-rated 
health and multimorbidity varied from 0.16 to 
1.25 indicating some asymmetry. Kurtosis var-
ied from −0.65 to 1.60, which, although <3.00, 
suggested mildly mesokurtic distributions, 
with both platykurtic (kurtosis < 0) and lepto-
kurtic (kurtosis > 0) bias (Westfall & Henning, 
2013). Consequently, it was decided to per-
form SEM using the Bollen-Stine bootstrap 
procedure, with 200 resamples, for testing the 
null hypothesis that the model is correct. The 
Bollen-Stine method is a modified bootstrap 
technique for the χ2 goodness of fit statistic, 
which provides a means to adjust for bias in 




Overall, 375 patients had been diagnosed 
with diabetes, of which 280 (74.67%) were 
told by a doctor or nurse they had type 2 dia-
betes (Figure 1). HbA1c data was unavailable 
for 95 patients (33.9%), otherwise all par-
ticipants had complete data for self-rated 
health, BMI, multimorbidity, comorbidities 
(heart disease, asthma/COPD, anxiety/depres-
sion), demographics (age, gender, social class) 
and physiological covariates (diastolic/sys-
tolic blood pressure, total/HDL cholesterol). 
The final study sample thus comprised 280 
patients, organised into six age groups, ranging 
from 24 to 75+ years (median/mode age group 
65–74 years, 52.5% male). Analysis of differ-
ences between Hba1c–complete and Hba1c–
missing patients, on socio-demographic 
factors, revealed that the latter group were 
more likely to be older (72% aged >65 years), 
χ2 (1, N = 280) = 9.56, p < 0.01. HbA1c–missing 
patients were less disposed to high total cho-
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p < 0.001, and more prone to low HDL cholesterol 
(HDL < 1), χ2 (1, N = 280) = 146.07, p < 0.001, 
and a history of heart disease, χ2 (1, N = 280) = 
8.92, p < 0.01. Sociodemographic and clinical 
parameters are shown in Table 1.
There was a significant association between 
self-rated health and multimorbidity (Figure 2); 
patients with multimorbidity (⩾2 LTCs) were 
more likely to view their health as ‘fair/bad/
very bad’ compared to those without multimor-
bidity, (χ2(1) = 45.22, p < 0.001). Patients with 
a history of heart disease were also more likely 
to report poor perceived health (χ2(1) = 11.07, 
p ⩽ 0.001). Negative views of health were also 
significantly more likely in patients with 
depression/anxiety (χ2(1) = 40.63, p < 0.001), 
and those on asthma/COPD medication 
(χ2(1) = 10.85, p ⩽ 0.001). Across the whole 
sample, 34.6% had been diagnosed with ⩾2 
chronic conditions, 43.2% had Hba1c levels 
>6.5% (indicating poor glycaemic control) 
(Sherwani et al., 2016) and 54% perceived their 
health as ‘fair/bad/very bad’. Furthermore, 
11.4% were taking asthma/COPD medication, 
36.1% suffered from anxiety/depression, 13.6% 
had a history of heart disease and 61.8% were 
obese (BMI > 30). Just over 60% of patients had 
systolic readings >120 mm Hg, while 18.6% 
had diastolic values >80 mm: 65.4% had doc-
tor-diagnosed hypertension. Almost half of the 
sample (48.6%) had a deficient HDL cholesterol 
level (<1), while 10.4% had high total choles-
terol (>5 mmol/L). The mean Hba1c level (185 
complete cases only), was 7.32% ± 1.44, which 
is over the recommended 6.5% cut-off for diag-
nosing diabetes. Patients reported an average of 
2.01 ± 1.36 chronic conditions diagnosed. The 
mean BMI was 32.61 ± 6.42, denoting a sample 
that is generally overweight.
Hypothesis 1: Logistic regression 
analysis
To reduce the risk of type 1 errors (false posi-
tives) a Bonferroni correction was applied. The 
resulting adjusted alpha level was circa 
p < 0.003, for the whole sample, and also each 
gender group. For consistency p < 0.001 was 
used as the default alpha level. Emerging logis-
tic regression estimates are shown in Tables 2 
to 4. Overall model parameters are displayed in 
Table 5. Demographic variables did not predict 
self-rated health (Model 1). Addition of multi-
morbidity variables (Model 2) resulted in good 
fit. The odds of reporting ‘fair/bad/very bad’ 
self-rated health was over 10 times higher in 
patients with three conditions (OR 10.53 
(3.93–28.21)), and over 14 times greater in 
those with four illnesses (OR 14.87 (4.70–
47.08)). The wide confidence intervals high-
light reduced certainty, and the need for further 
verification with a larger sample. Addition of 
physiological risk factors, notably total/HDL 
cholesterol, HbA1c and systolic/diastolic blood 
pressure (Model 3), did not attenuate associa-
tions between self-rated health and multimor-
bidity; having three (OR 12.39 (4.45–34.48) 
and four (OR 15.72 (4.82–51.21) conditions 
predicted poor perceived health. Inclusion of 
individual comorbidities, specifically obesity, 
heart disease, anxiety/depression and asthma/
COPD (Model 4), also failed to significantly 
alter associations between self-rated health and 
multimorbidity. The odds of reporting ‘fair/
bad/very bad’ self-rated health remained over 
10 times higher in patients with three condi-
tions (OR 10.11 (3.36–30.40)). However, the 
odds were now just 10 times greater in patients 
with four illnesses (OR 10.58 (2.92–38.25)), 
reduced from over fifteen (Model 3). One 
comorbidity was significant; the odds of ‘fair/
bad’ self-rated health was nearly five times 
greater in patients with anxiety/depression (OR 
4.75 (2.38–9.49)).
The regression was repeated separately by 
gender. In males, inclusion of multimorbidity 
variables (Model 2) produced a significant 
model. The odds of reporting ‘fair/bad/very 
bad’ self-rated health was about eight times 
higher in patients with three conditions (OR 
8.81 (2.30–33.64)). Adding physiological risk 
factors (cholesterol, HbA1c, blood pressure) 
(Model 3) did not significantly affect relations 
between perceived health and multimorbidity, 
albeit the odds of ‘fair/bad/very bad’ self-rated 
health increased slightly in patients with three 
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Figure 2. Frequencies for self-rated health by multimorbidity, HbA1c, BMI, cholesterol and individual 
comorbidities. Variables are dichotomised, to maximise cell frequencies.
*p ⩽ 0.001.
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diseases (OR 12.78 (3.06–53.26)). Including 
individual comorbidities (Model 4), also failed 
to attenuate the association between perceived 
health and multimorbidity (OR 12.46 (2.64–
58.84)). The odds of ‘fair/bad’ self-rated health 
was nearly eight times higher in patients with 
anxiety/depression (OR 7.83 (2.51–24.42)). As 
in the overall sample, wide confidence intervals 
with males indicated reduced certainty. In 
females, adding multimorbidity (Model 2) did 
not produce any significant associations with 
perceived health (all p’s > 0.001). These null 
results persisted after including physiological 
risk factors (Model 3) and comorbidities (Model 
4). Having three or four conditions approached 
significance in Models 2 and 3 (all p’s < 0.009, 
but >0.001).
Sensitivity analysis
The data was reanalysed with and without 
expectation maximisation applied to missing 
HbA1c data. Results generally supported the 
primary analysis. The odds of reporting ‘fair/
bad/very bad’ self-rated health remained sig-
nificantly higher in patients with three (OR 
13.21 (3.14–55.54)) or four conditions (OR 
24.72 (3.90–156.47)). As before, the odds of 
‘fair/bad’ self-rated health was significantly 
higher in patients with anxiety/depression (OR 
4.27 (1.80–10.15)). Results by gender also ech-
oed the primary analysis. In males, the odds of 
reporting ‘fair/bad/very bad’ self-rated health 
was higher in patients with three conditions 
(OR 22.65 (2.78–184.08), albeit not at the 
Bonferroni-adjusted alpha level of p < 0.003 
(observed p = 0.004). A similar pattern emerged 
for depression/anxiety. In females multimorbid-
ity did not produce any significant associations 
with perceived health (all p’s > 0.001). Overall, 
sensitivity analysis suggests that the primary 
analysis was robust.
Hypothesis 2: Structural equation 
modelling
The following thresholds were used to assess 
model fit (Hooper et al., 2008): model chi-
square χ2 (CMIN) (p > 0.05), χ2 (CMIN)/
df < 2.00, root mean square error of approxima-
tion (RMSEA) < 0.07, comparative fit index 
(CFI) ⩾ 0.95, Tucker and Lewis Index 
(TLI) ⩾ 0.95 and normed fit index (NFI) ⩾ 0.95. 
Due to ambiguity regarding interpretation of 
parsimony fit indices, specifically the parsi-
mony normed fit index (PNFI), these criteria 
were not used (Hooper et al., 2008). 
Furthermore, IBM AMOS SPSS (Version 26) 
does not generate root mean square residual 
(RMR) or standardised root mean square resid-
ual (SRMR) values. Finally, observed TLI val-
ues were subject to less stringent interpretation 
because this index can be lower than expected 
(i.e. <0.95) when small samples are employed, 
indicating poor fit, while other criteria denote 
good fit (Tabachnick and Fidell, 2007). An ini-
tial model was tested, consistent with 
Hypothesis 1: multimorbidity was allowed to 
affect HbA1c, both directly and indirectly, 
mediated by self-rated health; the direct and 
indirect effects of multimorbidity on BMI were 
also tested, again with perceived health treated 
as a mediator.
Goodness-of-fit parameters for this initial 
model were; χ2 (CMIN) = 4.34, df = 1, p = 0.037, 
χ2 (CMIN)/df = 4.34, RMSEA = 0.11, CFI = 0.96, 
TLI = 0.76 and NFI = 0.95. Despite the satisfac-
tory CFI and NFI values, the CMIN (p < 0.05), 
χ2 (CMIN)/df (>2) and RMSEA (>0.07), all 
indicated poor fit. The Bollen-Stine bootstrap 
result, based on 200 resamples, also indicated a 
poor fitting model (p = 0.035). Thus, it was 
decided to perform post-hoc modifications. The 
data was reanalysed using the AMOS specifica-
tion-search function, to test out different mod-
els. Specification-search provides a mechanism 
for systematically evaluating the fit of multiple 
candidate models, in order to identify the best 
fitting framework.
Of the 10 models generated one was chosen 
based primarily on the χ2 (CMIN)/df value. 
This model is presented in Figure 3. Maximum 
likelihood estimations are shown in Table 6. 
Multiple fit criteria indicated good fit: χ2 
(CMIN) = 5.10, df = 3, p = 0.164, χ2 (CMIN)/
df = 1.70, RMSEA = 0.05, CFI = 0.97, TLI = 0.95 
and NFI = 0.94 (requirements; CMIN (p > 0.05), 
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Table 2. Hierarchical regression models predicting self-rated health from multimorbidity and covariates 
(complete sample).
N = 279 B SE p OR CI
Model 1
 Age 0.18 0.25 0.453 1.20 0.73–1.97
 Social −0.70 0.25 0.005 0.49 0.30–0.81
 Gender 0.20 0.24 0.402 1.22 0.76–1.98
Model 2
 Age 0.09 0.28 0.734 1.10 0.63–1.91
 Social −0.84 0.28 0.003 0.43 0.24–0.75
 Gender −0.07 0.28 0.797 0.93 0.53–1.61
 1 LTC 0.20 0.44 0.644 1.23 0.51–2.95
 2 LTC 1.08 0.43 0.013 2.96 1.26–6.94
 3 LTC 2.35 0.50 <0.001* 10.53 3.93–28.21
 4 LTC 2.70 0.58 <0.001* 14.87 4.70–47.08
 5 LTC 3.15 1.11 0.005 23.51 2.63–209.74
Model 3
 Age 0.02 0.30 0.930 1.02 0.56–1.85
 Social −0.89 0.29 0.002 0.40 0.23–0.72
 Gender −0.19 0.29 0.505 0.82 0.45–1.46
 1 LTC 0.19 0.45 0.665 1.21 0.49–2.98
 2 LTC 1.23 0.45 0.006 3.44 1.42–8.34
 3 LTC 2.51 0.52 <0.001* 12.39 4.45–34.48
 4 LTC 2.75 0.60 <0.001* 15.72 4.82–51.21
 5 LTC 2.88 1.12 0.010 17.93 1.96–163.60
 Total cholesterol >5 mmol/L 0.02 0.48 0.967 1.02 0.39–2.61
 HDL cholesterol <1 0.07 0.37 0.846 1.07 0.51–2.23
 HbA1c >6% −0.71 0.38 0.064 0.49 0.23–1.04
 Diastolic BP >80 mm Hg −0.15 0.38 0.690 0.85 0.40–1.83
 Systolic BP >120 mm Hg −0.36 0.32 0.291 0.69 0.37–1.30
Model 4
 Age 0.09 0.33 0.774 1.10 0.56–2.13
 Social −0.62 0.32 0.054 0.53 0.28–1.01
 Gender −0.35 0.33 0.284 0.70 0.36–1.34
 1 LTC 0.12 0.49 0.804 1.13 0.42–2.99
 2 LTC 1.28 0.49 0.009 3.61 1.38–9.48
 3 LTC 2.31 0.56 <0.001* 10.11 3.36–30.40
 4 LTC 2.35 0.65 <0.001* 10.58 2.92–38.25
 5 LTC 2.10 1.17 0.074 8.23 0.81–83.10
 Total cholesterol >5 mmol/L 0.13 0.51 0.797 1.14 0.41–3.10
 HDL cholesterol < 1 0.04 0.40 0.908 1.04 0.47–2.30
 HbA1c >6% −0.71 0.41 0.081 0.48 0.21–1.09
 Diastolic BP >80 mm Hg −0.41 0.42 0.331 0.66 0.28–1.52
 Systolic BP >120 mm Hg −0.23 0.34 0.493 0.78 0.39–1.55
 Obese (BMI > 30), yes 0.16 0.32 0.622 1.17 0.62–2.22
 Heart disease, yes 0.92 0.52 0.078 2.51 0.90–7.01
 Depression/anxiety, yes 1.56 0.35 <0.001* 4.75 2.38–9.49
 Asthma/COPD medication, yes 0.81 0.56 0.150 2.25 0.74–6.85
Boldfaced values denote significant regression coefficients (Bonferroni-adjusted, p < 0.001). *denotes significant based 
on bootstrapping, with 1000 resamples (Bonferroni-adjusted, p ⩽ 0.001).
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Table 3. Hierarchical regression models predicting self-rated health from multimorbidity and covariates 
(males only).
n = 146 B SE p OR CI
Model 1
 Age 0.55 0.35 0.111 1.74 0.88–3.47
 Social −0.54 0.34 0.117 0.58 0.29–1.14
Model 2
 Age 0.82 0.40 0.041 2.27 1.03–5.00
 Social −1.06 0.40 0.008 0.34 0.15–0.75
 1 LTC −0.24 0.50 0.634 0.78 0.29–2.11
 2 LTC 0.48 0.53 0.369 1.61 0.56–4.61
 3 LTC 2.17 0.68 ⩽0.001* 8.81 2.30–33.64
 4 LTC 3.21 1.13 0.005 25.00 2.68–232.88
Model 3
 Age 0.68 0.46 0.154 1.95 0.77–4.88
 Social −1.12 0.43 0.010 0.32 0.13–0.76
 1 LTC −0.21 0.52 0.681 0.80 0.28–2.25
 2 LTC 0.67 0.56 0.239 1.95 0.64–5.96
 3 LTC 2.54 0.72 <0.001* 12.78 3.06–53.26
 4 LTC 3.24 1.17 0.006 25.65 2.58–225.15
 Total cholesterol >5 mmol/L 0.21 0.72 0.764 1.24 0.30–5.15
 HDL cholesterol <1 0.71 0.50 0.157 2.03 0.75–5.47
 HbA1c >6% −0.44 0.53 0.408 0.64 0.22–1.83
 Diastolic BP >80 mm Hg −0.44 0.57 0.437 0.63 0.20–1.97
 Systolic BP >120 mm Hg −0.46 0.45 0.309 0.62 0.25–1.53
Model 4
 Age 0.68 0.53 0.201 1.98 0.69–5.68
 Social −1.08 0.47 0.023 0.33 0.13–0.86
 1 LTC −0.27 0.60 0.648 0.75 0.23–2.49
 2 LTC 0.89 0.63 0.160 2.43 0.70–8.42
 3 LTC 2.52 0.79 ⩽0.001* 12.46 2.64–58.84
 4 LTC 2.64 1.24 0.034 14.01 1.22–160.20
 Total cholesterol >5 mmol/L 0.95 0.82 0.247 2.60 0.51–13.13
 HDL cholesterol <1 0.71 0.54 0.186 2.05 0.70–5.95
 HbA1c >6% −0.87 0.59 0.143 0.41 0.13–1.34
 Diastolic BP >80 mm Hg −0.92 0.68 0.178 0.39 0.10–1.52
 Systolic BP >120 mm Hg −0.59 0.51 0.249 0.55 0.20–1.51
 Obese (BMI >30), yes −0.41 0.48 0.391 0.66 0.25–1.70
 Heart disease, yes 0.29 0.65 0.653 1.34 0.37–4.81
 Depression/anxiety, yes 2.05 0.58 <0.001* 7.83 2.51–24.42
 Asthma/COPD medication, yes 0.85 0.79 0.281 2.36 0.49–11.26
Boldfaced values denote significant regression coefficients (Bonferroni-adjusted, p ⩽ 0.001). *denotes significant based 
on bootstrapping, with 1000 resamples (Bonferroni-adjusted, p ⩽ 0.001). The ‘5 LTC’ dummy variable is excluded due to 
low cell frequencies.
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Table 4. Hierarchical regression models predicting self-rated health from multimorbidity and covariates 
(females only).
n = 133 B SE p OR CI
Model 1
 Age −0.21 0.36 0.561 0.80 0.39–1.65
 Social −0.88 0.37 0.017 0.41 0.19–0.85
Model 2
 Age −0.56 0.41 0.172 0.56 0.25–1.27
 Social −0.83 0.40 0.040 0.43 0.19–0.96
 1 LTC −0.54 0.66 0.413 0.58 0.15–2.12
 2 LTC 0.64 0.56 0.249 1.91 0.63–5.77
 3 LTC 1.78 0.66 0.007 5.96 1.61–22.03
 4 LTC 1.87 0.70 0.008 6.53 1.63–26.11
Model 3
 Age −0.52 0.42 0.222 0.59 0.25–1.37
 Social −0.92 0.42 0.030 0.39 0.17–0.91
 1 LTC −0.68 0.70 0.328 0.50 0.12–1.99
 2 LTC 0.76 0.60 0.210 2.14 0.65–7.05
 3 LTC 1.82 0.70 0.009 6.18 1.56–24.40
 4 LTC 1.93 0.72 0.008 6.92 1.66–28.80
 Total cholesterol >5 mmol/L 0.00 0.64 0.996 1.00 0.28–3.52
 HDL cholesterol <1 −0.24 0.57 0.671 0.78 0.25–2.42
 HbA1c >6% −0.89 0.57 0.119 0.40 0.13–1.26
 Diastolic BP >80 mm Hg 0.43 0.58 0.454 1.54 0.49–4.85
 Systolic BP >120 mm Hg −0.14 0.44 0.747 0.86 0.36–2.07
Model 4
 Age −0.40 0.49 0.414 0.55 0.25–1.75
 Social −0.38 0.53 0.470 0.68 0.24–1.92
 1 LTC −0.91 0.84 0.284 0.40 0.07–2.12
 2 LTC 0.79 0.73 0.279 2.21 0.52–9.33
 3 LTC 1.84 0.80 0.022 6.34 1.31–30.66
 4 LTC 1.49 0.86 0.083 4.46 0.82–24.27
 Total cholesterol >5 mmol/L 0.03 0.70 0.962 1.03 0.26–4.12
 HDL cholesterol <1 −0.74 0.65 0.257 0.47 0.13–1.71
 HbA1c >6% −0.89 0.64 0.165 0.41 0.11–1.44
 Diastolic BP >80 mm Hg 0.17 0.66 0.799 1.18 0.32–4.38
 Systolic BP >120 mm Hg 0.13 0.51 0.795 1.14 0.41–3.14
 Obese (BMI >30), yes 0.78 0.49 0.110 2.19 0.83–5.75
 Heart disease, yes 2.21 1.18 0.061 9.14 0.90–92.65
 Depression/anxiety, yes 1.48 0.51 0.004 4.39 1.59–12.12
 Asthma/COPD medication, yes 2.14 1.15 0.064 8.52 0.87–82.64
There are no significant regression coefficients (all p’s > 0.001, Bonferroni-adjusted). There are also no significant coef-
ficients based on bootstrapping, with 1000 resamples (all p’s > 0.001, Bonferroni-adjusted). The ‘5 LTC’ dummy variable 
is excluded due to low cell frequencies.


















































































































































































































































































































































































































































































































































































































































































































































































χ2 (CMIN)/df (<2), RMSEA (<0.07), CFI 
(⩾0.95) and TLI (⩾0.95)). Although the NFI 
was borderline (<0.95), this criterion is sensi-
tive to sample size; it tends to underestimate fit 
for samples <200 (Hooper et al., 2008). The 
Bollen-Stine bootstrapping test was non-signif-
icant, denoting good fit (p = 0.159): the model 
provided a better fit in 169 bootstrap samples, 
fit equally well in zero samples and gave a 
worse fit or failed to fit in just 31 samples.
It was hypothesised that multimorbidity is 
indirectly related to both HbA1c and BMI, 
mediated by self-rated health. The model 
showed that multimorbidity was associated 
with perceived health; patients with multiple 
conditions reported poorer health evaluations 
(β = 0.48, p < 0.001). The direct associations 
of multimorbidity with HbA1c and BMI were 
not statistically significant. Self-rated health 
was related to body weight; patients with more 
negative assessments had higher BMI scores 
(β = 0.17, p = 0.003). However, perceived 
health was unrelated to HbA1c, negating the 
proposition that the former mediates relations 
between multimorbidity and glycaemic con-
trol. Squared multiple correlations showed the 
default model explained 23.5% and 3.1% of 
the variance in self-rated health and BMI, 
respectively. Confidence in the fit of the model 
was enhanced by the CFI value of 0.97 
(⩾0.95), as this fit index is least affected by 
sample size (Hooper et al., 2008). The TLI 
Figure 3. Optimal structural equation model, using search specification (AMOS, v.26). The SRH → HbA1c 
pathway is not significant (p > 0.05).
Table 6. Maximum likelihood estimation results.
Estimate SE CR p Label
Self-rated health ← Multimorbidity 0.485 0.033 9.254 *** Supported
HbA1c (glycaeted haemoglobin) ← Multimorbidity 0.000 − − − Not significant
Body mass index ← Multimorbidity 0.000 − − − Not significant
HbA1c (glycaeted haemoglobin) ← Self-rated health −0.095 0.081 −1.598 0.110 Not significant
Body mass index ← Self-rated health 0.176 0.436 2.980 0.003 Supported
Estimates are standardised regression weights (default model). ***indicate p < 0.001. HbA1c is calibrated in percentages, 
not mmol/mol.
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value (⩾95) also indicated good fit, despite a 
propensity to denote poor fit when modest 
sample sizes are used (Tabachnick and Fidell, 
2007).
Discussion
This is the first study to assess how self-rated 
health relates to multimorbidity, glycaemia 
and body weight, in adult patients with type 2 
diabetes. Previous studies on self-rated health 
and multimorbidity have focused on generic 
or healthy populations (Bustos-Vazquez et al., 
2017; Ishizaki et al., 2019; Mavaddat et al., 
2014; Song et al., 2018). Research specifi-
cally examining people with diabetes is rare. 
The present study tested two propositions: 
that greater multimorbidity is associated with 
poorer self-rated health (Hypothesis 1) and 
multimorbidity is indirectly related to both 
glycaemia and BMI, mediated by self-rated 
health (Hypothesis 2). Data analysis revealed 
support for Hypothesis 1 and partial verifica-
tion of Hypothesis 2.
Hypothesis 1
Self-rated health was associated with multi-
morbidity, after adjusting for HbA1c, obesity, 
other physiological risk factors and individual 
comorbidities. Patients with multimorbidity 
(three or four conditions) were multiple times 
more likely to report poor perceived health, 
echoing previous research (Bustos-Vazquez 
et al., 2017; Ishizaki et al., 2019; Song et al., 
2018). Gender played an important role; while 
multimorbidity predicted self-rated health in 
males, the data for females was ambiguous. 
This asymmetry reflects previous research 
showing a more pronounced link between mul-
timorbidity and perceived health in men com-
pared to women (Mavaddat et al., 2014). 
However, some research has found no gender 
differences (Galenkamp et al., 2011). One pos-
sible reason for these inconsistencies is that 
relations between multimorbidity and self-rated 
health are underpinned by complex human 
judgements about the seriousness of one or 
multiple illnesses, which may vary by gender, 
and also be specific to patients with a particular 
disease (Idler and Benyamini, 1997).
A review of men and women’s adjustment to 
diabetes-related challenges found that male 
patients live more effectively with diabetes, 
experiencing less depression and anxiety 
(Siddiqui et al., 2013). However, other research 
suggests depression is the main reason multi-
morbid men perceive poor health, whereas 
depression is just one of many factors influenc-
ing multimorbidity and self-rated health in 
females (Assari et al., 2019). Another possible 
explanation is that males experience more 
severe multimorbidity than females, leading to 
poorer health assessments (Idler and Benyamini, 
1997). The present data suggests males reported 
fewer illnesses compared to females (see Table 
1). Nevertheless, male patients may experience 
more severe symptoms due to less use of diabe-
tes health services (Siddiqui et al., 2013). 
Additionally, diminished social activity has 
been associated with poor self-rated health in 
older men (Caetano et al., 2013). Less social 
activity in multimorbid men may precipitate 
more pessimistic assessments of general well-
being. Overall, more research is needed to bet-
ter understand the complex biopsychosocial 
factors underpinning gender differences in mul-
timorbidity and self-rated health.
Hypothesis 2
Although multimorbidity predicted self-rated 
health, neither was associated with HbA1c, con-
tradicting previous research (Abualula et al., 
2018; Nielsen et al., 2011). However, the present 
data supports a recent systematic review in which 
the majority of studies found no multimorbidity–
HbA1c connection (Chiang et al., 2018). Self-
rated health did mediate multimorbidity–BMI 
relations, whereby presence of multiple diseases 
and being overweight were underpinned by poor 
perceived health. Past research has established 
associations between body weight and poor 
self-rated health (Wang and Arah, 2015); 
the present findings suggest the role of per-
ceived health goes further, in type 2 
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diabetes, partly explaining the obesity–multi-
morbidity relationship (Madlock-Brown and 
Reynolds, 2019).
Although there is abundant evidence on obe-
sity-related multimorbidity (Agborsangaya 
et al., 2013; Agrawal and Agrawal, 2016; Booth 
et al., 2014; Kivimaki et al., 2017; Madlock-
Brown and Reynolds, 2019), no study has 
examined self-rated health in this context, espe-
cially amongst people with diabetes. Previous 
research indicates obesity–related multimorbid-
ity depends on socio-cultural characteristics 
(Madlock-Brown and Reynolds, 2019). The 
present findings suggest self-rated health is also 
an important underlying factor. The term ‘obe-
sity-related multimorbidity’, used to describe 
common obesity-related groupings of multi-
morbidities in a recent paper (Madlock-Brown 
and Reynolds, 2019), is appropriate here since 
body weight was associated with multimorbid-
ity, albeit indirectly, mediated by perceived 
health. Patients with multiple illnesses are per-
haps more likely to view their health as deterio-
rating, and consequently lose motivation to 
adopt weight management behaviours (Idler 
and Benyamini, 1997).
Limitations
Expectation-maximisation was used to estimate 
missing HbA1c values because this method is 
generally considered superior to other tech-
niques for resolving missing data (e.g. mean 
substitution), which generate biased estimates. 
Nevertheless, how these estimations affected 
the findings is unclear. Sensitivity analyses did 
not produce any significant changes in the inter-
pretation of the data from logistic regression 
analysis. Nevertheless, the marginally less 
robust alpha level observed in males (p = 0.004) 
may point to the need for future research to 
address the source of this discrepancy. 
Simulation studies comparing multiple 
approaches of resolving missing data may be 
necessary. Expectation maximisation converges 
to a local solution, necessitating further research 
to verify the present results using alternative 
methods for managing missing data. Another 
problem is failure to assess the severity, dura-
tion and type of multimorbidities. For example, 
two people with diabetes experiencing exactly 
the same number and type of chronic conditions 
may nevertheless develop highly divergent self-
perceptions of health, due to variation in symp-
tom severity.
Extending the current observations to other 
chronic disease populations is an important 
avenue for future research. In particular, future 
studies should examine the extent to which the 
findings generalise to patients with type 1 dia-
betes (who are typically younger). The HbA1c 
test is also used to evaluate glycaemic control 
and predict complications in type 1 patients 
(Sherwani et al., 2016). Future research should 
test mediation models in type 1 patients, to see 
how self-rated health affects relations between 
multimorbidity and HbA1c. Patients in this 
study were in better glycaemic condition than 
expected (most generating HbA1c levels 
<6.5%). They also reported less multimorbid-
ity (just 34.6% had ⩾2 conditions, compared to 
90% reported elsewhere) (Teljeur et al., 2013). 
Thus, the current sample isn’t representative. 
Furthermore, HbA1c levels depend on diabetes 
history, medication regimes and short/long-
term insulin dosage (Sherwani et al., 2016). It is 
therefore essential for future research to control 
for these confounders.
Implications
The current findings may have implications for 
patient care. In clinical settings, self-rated 
health may be measured as part of routine 
patient monitoring, and/or during initial con-
sultation, or registration. Since detection of 
multimorbidity continues to present a chal-
lenge for physicians (diagnostic uncertainty) 
(Hausmann et al., 2019), self-rated health can 
be used as a reliable marker for multimorbidity 
in people with diabetes, ancillary to other diag-
nostic criteria used by doctors. Perceived 
health arguably captures the full array of ill-
nesses a person is experiencing, including 
undiagnosed morbidity still at a preclinical or 
prodromal stage (Idler and Benyamini, 1997). 
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Thus, a patient reporting poor self-rated health 
can be referred for further clinical testing, to 
identify any disease clusters. This scenario is 
primarily applicable to men, given the tenuous 
link between perceived health and multimor-
bidity in women. Self-rated health might also 
help identify patients with obesity-related mul-
timorbidity (Madlock-Brown and Reynolds, 
2019). In this context it is possible efforts to 
improve self-rated health in patients with mul-
timorbidity could also support attempts at 
weight control (which could further improve 
outcomes for people with T2DM), but are 
unlikely to have a substantive impact on 
HbA1c.
Conclusion
The relationship between multimorbidity and 
self-rated health is well established. This is the 
first investigation of how self-rated health 
relates to multimorbidity, glycaemia and body 
weight, specifically in adult patients with type 2 
diabetes. The findings indicate patients with 
multimorbidity have poorer self-rated health. 
Furthermore, perceived health underpins obe-
sity-related multimorbidity in this clinical pop-
ulation, albeit neither self-rated health nor 
multimorbidity predicts HbA1c. Thus, how 
patients with type 2 diabetes view their health is 
unconnected to glycaemic control. Overall, this 
study highlights the potential of self-rated 
health to explain relationships between multi-
morbidity and BMI, but not glycaemic control, 
in people with type 2 diabetes. The role of self-
rated health in glycaemia seems more obfus-
cated than was previously thought, and entail 
underlying mechanisms that have yet to be fully 
understood.
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